Tema Neuroscience and Mental Health ETF
MNTL
Market cap $10M

22.74 USD

-0.23

1.00%

At close Jun 13, 4:00 PM EDT

1 day

-1.00%

5 days

-1.13%

1 month

3.50%

3 months

-4.61%

6 months

-8.34%

Year to date

-7.60%

1 year

-9.83%

5 years

-10.79%

10 years

-10.79%

Funds holding %

of 7,296 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

25% more capital invested

Capital invested by funds: $628K [Q4 2024] → $786K (+$158K) [Q1 2025]

1.9% more ownership

Funds ownership: 5.83% [Q4 2024] → 7.73% (+1.9%) [Q1 2025]

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

25% less funds holding

Funds holding: 4 [Q4 2024] → 3 (-1) [Q1 2025]

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for MNTL.

See Analyst Rankings

Financial journalist opinion

Neutral

ETF Trends

6 months ago

Hone Your Biotech Allocation in Neuroscience ETF MNTL

Tech investing poses one of the more important, and more fascinating, questions before investors entering 2025. Tech firms contributed outsized returns for the whole market, but do they pose concentration risks?

Positive

Schwab Network

1 year ago

MNTL ETF: Neuroscience & Mental Health ETF

Tema ETFs recently launched the neuroscience and mental health ETF. MNTL ETF is designed to invest in companies at the forefront of combating neurological diseases and psychiatric disorders.